---
title: "Neumora Therapeutics (NMRA.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NMRA.US/norm.md"
symbol: "NMRA.US"
name: "Neumora Therapeutics"
parent: "https://longbridge.com/en/quote/NMRA.US.md"
datetime: "2026-03-17T21:34:55.590Z"
locales:
  - [en](https://longbridge.com/en/quote/NMRA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NMRA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NMRA.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NMRA.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NMRA.US/norm.md)


# Neumora Therapeutics (NMRA.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3507 | -0.3261 | -0.4211 | -0.3654 | -0.4546 |
| ROE | -144.12% | -102.58% | -105.53% | -77.42% | -82.67% |
| Revenue | - | - | - | - | - |
| Net income | -56.76M | -52.73M | -67.99M | -58.82M | -72.55M |
| Operating income | -52.70M | -54.04M | -70.94M | -62.92M | -76.65M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 177.83M | 223.82M | 256.75M | 316.97M | 352.54M |
| Leverage | 1.35 | 1.22 | 1.12 | 1.10 | 1.10 |
| BVPS | 0.8161 | 1.13 | 1.41 | 1.78 | 2.00 |
| Turnover | - | - | - | - | - |
| Cash & STI | 171.53M | 217.59M | 249.35M | 307.58M | 341.31M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 554000.00 | 618000.00 | 1.88M | 2.92M | 3.93M |
| Net debt | -151.44M | -197.63M | -248.41M | -305.73M | -338.56M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -46.63M | -52.40M | -59.45M | -50.34M | -33.48M |
| Investing CF | 51.32M | 30.40M | 44.16M | -98.80M | 156.99M |
| Financing CF | -136000.00 | 18.46M | - | 15.57M | 1.53M |
| Free CF | -22.59M | -32.86M | -34.48M | -29.41M | -8.94M |
| OCF coverage | -291456.25% | - | - | 6495.48% | - |
| Repaid & issued | -136000.00 | 18.40M | - | - | - |
| CapEx | -16000.00 | - | - | 775000.00 | 0.0000 |